DNY59 J.P. Morgan said its top biotech picks for 2025 were Vertex ( NASDAQ: VRTX ), Travere ( NASDAQ: TVTX ), SpringWorks ( NASDAQ: SWTX ), PTC Therapeutics ( NASDAQ: PTCT ), Wave Life Sciences ( NASDAQ: WVE ), Xenon Pharmaceuticals ( NASDAQ: XENE ), Edgewise Therapeutics ( NASDAQ: EWTX ), Blueprint ( NASDAQ: BPMC ) and Roivant ( NASDAQ: ROIV ).
The investment bank said it could.
Health